Strutture
Servizi
Contenuto della pagina - Torna all'inizio
- Cardiologia
- Clinica Medica, Trombosi ed emostasi, ematologia dell'anziano
- Endocrinologia e Oncologia Medica
- Farmacologia Clinica e Sperimentale
- Farmacologia e Tossicologia Cellulare e Molecolare
- Geriatria
- Malattie Infettive
- Medicina Interna e Gastroenterologia
- Medicina Interna, Malattie Vascolari e Metaboliche
- Nefrologia, Dialisi, Trapianto
- Pediatria e Adolescentologia
- Pneumologia
- Reumatologia
![]() | Emilio PeruccaProfessore Ordinario di Farmacologia - in quiescenza dal 1 ottobre 2021 Sede: Unità di Farmacologia Clinica e Sperimentale Via Ferrata 9/A |
Telefono | + 39 0382 986360 |
perucca@unipv.it | |
Orari di ricevimento | Dal lunedì al venerdì dalle 9,00 alle 12,00 |
Insegnamenti |
|
Curriculum | CV Perucca |
Pubblicazioni | 1. BRODIE, M.J., PERUCCA, E., RYVLIN, P., BEN-MENACHEM, E., MEENCKE H.J., FOR THE LEVETIRACETAM MONOTHERAPY STUDY GROUP. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy . Neurology 2007;68: 402-408. 2. SAETRE, E., PERUCCA, E., ISOJARVI, J. and GJERSTAD, L., on behalf of the LAM 40089 Study Group. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007;48:1292-1302. 3. PERUCCA, E., FRENCH, J. and BIALER, M. Development of new antiepileptic drugs: Challenges, incentives, and recent advances. Lancet Neurol. 2007; 6:793-804. 4. PATSALOS, P.N., BERRY, D.J., BOURGEOIS, B.F.D., CLOYD, J.C., GLAUSER, T.A., JOHANNESSEN, S.I., LEPPIK, I., TOMSON, T and PERUCCA, E. Antiepileptic Drugs Best Practice Guidelines for Therapeutic Drug Monitoring: A Position Paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-1276. 5. PERUCCA, E., CLOYD, J., CRITCHLEY, D. and FUSEAU, E. Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia 2008;49:1123-1141. 6. PERUCCA, E. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions. CNS Drugs 20008;22:917-938. 7. ARZIMANOGLOU, A., FRENCH, J., BLUME, W.T., CROSS, J.H., ERNST, J.P., FEUCHT, M., GENTON, P., GUERRINI, R., KLUGER, G., PELLOCK, J.M., PERUCCA, E. and WHEELES J.W. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82-93. 8. CANEVINI, M.P., DE SARRO, G., GALIMBERTI, C.A., GATTI, G., LICCHETTA, L., MALERBA, A., MUSCAS, G., LANEVE, A., STRANO, P., and PERUCCA, E. on behalf of the SOPHIE Study Group. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010; 51:797-804 9. FATTORE, C, BONIVER, C, CAPOVILLA, G., CERMINARA, C., CITTERIO, A., COPPOLA, G., COSTA, P., DARRA, F., VECCHI M. and PERUCCA, E. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 2011;52: 802-809. 10. PERUCCA, E, TOMSON T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 10, 446-56, 2011 |
Collaborazioni | Institute for Children and Adolescents with Epilepsy (IDEE), Hospices Civils de Lyon, Department of Functional Neurology and Epileptology, Lyon, France (Prof.s Philippe Ryvlin, Alexis Arzimanoglou) Institute for Drug Research, School of Pharmacy and David R. Bloom Center for Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel (Prof. Meir Bialer) NYU Comprehensive Epilepsy Center, 223 East 34th Street, New York, USA (Prof. Jackie French) Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden (Prof. Torbjorn Tomson) Ribeirão Preto Medical School University Hospital, University of São Paulo, São Paulo, Brazil (Prof. Veriano Alexandre) |